Published in Cancer Imaging on March 16, 2010
Radiotherapy planning using MRI. Phys Med Biol (2015) 0.93
Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med (2003) 9.09
Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet (2008) 8.12
Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst (2008) 6.13
MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study. Lancet Oncol (2008) 2.76
Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology (2003) 2.24
The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis. Clin Radiol (2008) 2.19
FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina. Semin Surg Oncol (1994) 2.10
Mapping pelvic lymph nodes: guidelines for delineation in intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys (2005) 2.00
Accuracy of 18F-FDG PET/CT in detecting pelvic and paraaortic lymph node metastasis in patients with endometrial cancer. AJR Am J Roentgenol (2008) 1.66
Detection of pelvic lymph node metastases in gynecologic malignancy: a comparison of CT, MR imaging, and positron emission tomography. AJR Am J Roentgenol (2001) 1.53
FDG-PET for management of cervical and ovarian cancer. Gynecol Oncol (2005) 1.52
Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy. Gynecol Oncol (1996) 1.49
Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study. Radiology (2003) 1.42
Prostate cancer: detection of lymph node metastases outside the routine surgical area with ferumoxtran-10-enhanced MR imaging. Radiology (2009) 1.34
Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis. Lancet Oncol (2006) 1.32
Results and complications of operative staging in cervical cancer: experience of the Gynecologic Oncology Group. Gynecol Oncol (1980) 1.24
Rectal cancer: mesorectal lymph nodes at MR imaging with USPIO versus histopathologic findings--initial observations. Radiology (2004) 1.24
Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. J Clin Oncol (2005) 1.22
Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT. Radiology (2005) 1.22
Conservative surgery for carcinoma of the cervix. Clin Oncol (R Coll Radiol) (2008) 1.19
Detection of lymph node metastasis in cervical and uterine cancers by diffusion-weighted magnetic resonance imaging at 3T. J Magn Reson Imaging (2008) 1.19
Comparison of dynamic helical CT and dynamic MR imaging in the evaluation of pelvic lymph nodes in cervical carcinoma. AJR Am J Roentgenol (2000) 1.18
Lymph node metastases: safety and effectiveness of MR imaging with ultrasmall superparamagnetic iron oxide particles--initial clinical experience. Radiology (1998) 1.17
Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET. Radiology (2001) 1.17
Normal pelvic lymph nodes: evaluation with CT after bipedal lymphangiography. Radiology (1995) 1.13
Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional TI-weighted magnetization-prepared-rapid gradient-echo sequence. AJR Am J Roentgenol (1996) 1.12
The diagnostic value of PET/CT scanning in patients with cervical cancer: a prospective study. Gynecol Oncol (2007) 1.10
Evaluation of FDG PET in patients with cervical cancer. J Nucl Med (1999) 1.08
Diagnosis, staging, and surveillance of cervical carcinoma. AJR Am J Roentgenol (2003) 1.03
Detection and evaluation of pelvic lymph nodes in patients with gynecologic malignancies using body diffusion-weighted magnetic resonance imaging. J Comput Assist Tomogr (2008) 1.02
Ferumoxtran-10-enhanced MR lymphangiography: does contrast-enhanced imaging alone suffice for accurate lymph node characterization? AJR Am J Roentgenol (2006) 0.98
Use of ultrasmall superparamagnetic iron oxide in lymph node MR imaging in prostate cancer patients. Eur J Radiol (2007) 0.94
Accuracy of integrated FDG-PET/contrast-enhanced CT in detecting pelvic and paraaortic lymph node metastasis in patients with uterine cancer. Eur Radiol (2009) 0.93
Low value of [18F]-fluoro-2-deoxy-D-glucose positron emission tomography in primary staging of early-stage cervical cancer before radical hysterectomy. J Clin Oncol (2006) 0.92
Lymphotropic nanoparticle enhanced MR imaging (LNMRI) technique for lymph node imaging. Eur J Radiol (2006) 0.91
Cross-sectional imaging of nodal metastases in the abdomen and pelvis. Abdom Imaging (2007) 0.90
An update on vulvar cancer. Am J Obstet Gynecol (2001) 0.85
Prostate cancer evaluated with ferumoxtran-10-enhanced T2*-weighted MR Imaging at 1.5 and 3.0 T: early experience. Radiology (2006) 0.85
Decrease of signal intensity of myometrium and cervical stroma after ultrasmall superparamagnetic iron oxide (USPIO) particles administration: an MR finding with potential benefits in T staging of uterine neoplasms. Invest Radiol (2004) 0.82
USPIO-enhanced MRI for preoperative staging of gynecological pelvic tumors: preliminary results. Eur Radiol (2004) 0.81
Comparison of lymphotropic nanoparticle-enhanced MRI sequences in patients with various primary cancers. AJR Am J Roentgenol (2006) 0.79
Magnetic resonance lymphography: a novel technique for lymph node assessment in gynecologic malignancies. Cancer Biomark (2009) 0.79
Pearls and pitfalls of MR lymphography in gynecologic malignancy. Radiographics (2009) 0.78
Uterine malignancies. Clin Oncol (R Coll Radiol) (2008) 0.77
Controversies in the management of vulvar carcinoma. Br J Obstet Gynaecol (1996) 0.76
Sequential FDG-PET/CT as a biomarker of response to Sunitinib in metastatic clear cell renal cancer. Clin Cancer Res (2011) 1.51
The role of dynamic contrast-enhanced and diffusion weighted magnetic resonance imaging in the female pelvis. Eur J Radiol (2010) 1.23
Fibrosis and carcinoid syndrome: from causation to future therapy. Nat Rev Endocrinol (2009) 1.12
Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours. Eur J Endocrinol (2004) 1.06
Effectiveness of semi-quantitative multiphase dynamic contrast-enhanced MRI as a predictor of malignancy in complex adnexal masses: radiological and pathological correlation. Eur Radiol (2011) 1.05
Radiological appearances of gynaecological emergencies. Insights Imaging (2012) 1.04
Can quantitative dynamic contrast-enhanced MRI independently characterize an ovarian mass? Eur Radiol (2010) 1.00
Acute abdominal and pelvic pain in pregnancy: ESUR recommendations. Eur Radiol (2013) 0.98
Cushing's syndrome caused by an occult source: difficulties in diagnosis and management. Nat Clin Pract Endocrinol Metab (2006) 0.92
Diagnosis and localisation of insulinoma: the value of modern magnetic resonance imaging in conjunction with calcium stimulation catheterisation. Eur J Endocrinol (2010) 0.92
Interesting case of ovarian sarcoidosis: the value of multi disciplinary team working. World J Surg Oncol (2007) 0.87
Adnexal masses: development and preliminary validation of an MR imaging scoring system. Radiology (2013) 0.86
Advances in magnetic resonance imaging of endometrial cancer. Eur Radiol (2010) 0.85
Radiological manifestations of metastasis to the ovary. J Clin Pathol (2012) 0.82
Human plasma cells express granzyme B. Eur J Immunol (2013) 0.81
Off-the-shelf adenoviral-mediated immunotherapy via bicistronic expression of tumor antigen and iMyD88/CD40 adjuvant. Mol Ther (2012) 0.81
Therapeutic monitoring of gastroenteropancreatic neuroendocrine tumors: the challenges ahead. Neuroendocrinology (2012) 0.81
The MRI features of histologically proven ovarian cystadenofibromas-an assessment of the morphological and enhancement patterns. Eur Radiol (2012) 0.80
A rare case of small bowel obstruction secondary to ovarian torsion in an IVF pregnancy. BMJ Case Rep (2013) 0.78
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine & Hybrid Imaging. Neuroendocrinology (2017) 0.76
Functional imaging to predict tumor response in locally advanced cervical cancer. Curr Oncol Rep (2013) 0.76
Radiological Imaging: Computed Tomography, Magnetic Resonance Imaging and Ultrasonography. Front Horm Res (2015) 0.75
European Society of Gynaecologic Oncology Quality Indicators for Advanced Ovarian Cancer Surgery. Int J Gynecol Cancer (2016) 0.75